IQVIA HOLDINGS INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
IQVIA HOLDINGS INC. (IQV) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $66.00 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-05-05
- IQVIA HOLDINGS INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $66.00M, a 1.54% increase year-over-year.
- IQVIA HOLDINGS INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $51.00M, a 10.87% increase year-over-year.
- IQVIA HOLDINGS INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $52.00M, a 18.18% increase year-over-year.
- IQVIA HOLDINGS INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $65.00M, a 32.65% increase year-over-year.
- IQVIA HOLDINGS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $227.00M, a 25.41% increase from fiscal 2024.
- IQVIA HOLDINGS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $181.00M, a 5.24% decline from fiscal 2023.
- IQVIA HOLDINGS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $191.00M, a 0.52% decline from fiscal 2022.
- IQVIA HOLDINGS INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $192.00M, a 22.29% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month as first filed | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-03-31 | $66.00M 10-Q · filed 2026-05-05 | |||||
| 2025-12-31 | $227.00M 10-K · filed 2026-02-17 | |||||
| 2025-09-30 | $51.00M 10-Q · filed 2025-10-28 | $103.00M derived: sum of 2 quarters · filed 2025-10-28 | $168.00M derived: sum of 3 quarters · filed 2026-05-05 | |||
| 2025-06-30 | $52.00M 10-Q · filed 2025-10-28 | $117.00M derived: sum of 2 quarters · filed 2026-05-05 | ||||
| 2025-03-31 | $65.00M 10-Q · filed 2026-05-05 | |||||
| 2024-12-31 | $181.00M 10-K · filed 2026-02-17 | |||||
| 2024-09-30 | $46.00M 10-Q · filed 2025-10-28 | $90.00M derived: sum of 2 quarters · filed 2025-10-28 | $139.00M derived: sum of 3 quarters · filed 2025-10-28 | |||
| 2024-06-30 | $44.00M 10-Q · filed 2025-10-28 | $93.00M derived: sum of 2 quarters · filed 2025-10-28 | ||||
| 2024-03-31 | $49.00M 10-Q · filed 2025-10-28 | |||||
| 2023-12-31 | $191.00M 10-K · filed 2026-02-17 | |||||
| 2023-09-30 | $42.00M 10-Q · filed 2024-10-31 | $85.00M derived: sum of 2 quarters · filed 2024-10-31 | $154.00M derived: sum of 3 quarters · filed 2024-10-31 | |||
| 2023-06-30 | $43.00M 10-Q · filed 2024-10-31 | $112.00M derived: sum of 2 quarters · filed 2024-10-31 | ||||
| 2023-03-31 | $69.00M 10-Q · filed 2024-10-31 | |||||
| 2022-12-31 | $192.00M 10-K · filed 2025-02-13 | |||||
| 2022-09-30 | $69.00M 10-Q · filed 2024-05-02 | $64.00M 10-Q · filed 2022-10-27 | $116.00M derived: sum of 2 quarters · filed 2024-05-02 | $151.00M derived: sum of 3 quarters · filed 2024-05-02 | ||
| 2022-06-30 | $47.00M 10-Q · filed 2023-11-01 | $82.00M derived: sum of 2 quarters · filed 2023-11-01 | ||||
| 2022-03-31 | $35.00M 10-Q · filed 2023-11-01 | |||||
| 2021-12-31 | $157.00M 10-K · filed 2024-02-15 | |||||
| 2021-09-30 | $48.00M 10-Q · filed 2022-10-27 | $90.00M derived: sum of 2 quarters · filed 2022-10-27 | $120.00M derived: sum of 3 quarters · filed 2022-10-27 | |||
| 2021-06-30 | $42.00M 10-Q · filed 2022-10-27 | $72.00M derived: sum of 2 quarters · filed 2022-10-27 | ||||
| 2021-03-31 | $30.00M 10-Q · filed 2022-10-27 | |||||
| 2020-12-31 | $90.00M 10-K · filed 2023-02-15 | |||||
| 2020-09-30 | $30.00M 10-Q · filed 2021-10-22 | $60.00M derived: sum of 2 quarters · filed 2021-10-22 | $67.00M derived: sum of 3 quarters · filed 2021-10-22 | |||
| 2020-06-30 | $30.00M 10-Q · filed 2021-10-22 | $37.00M derived: sum of 2 quarters · filed 2021-10-22 | ||||
| 2020-03-31 | $7.00M 10-Q · filed 2021-10-22 | |||||
| 2019-12-31 | $137.00M 10-K · filed 2022-02-16 | |||||
| 2019-09-30 | $30.00M 10-Q · filed 2020-10-22 | $59.00M derived: sum of 2 quarters · filed 2020-10-22 | $80.00M derived: sum of 3 quarters · filed 2020-10-22 | |||
| 2019-06-30 | $29.00M 10-Q · filed 2020-10-22 | $50.00M derived: sum of 2 quarters · filed 2020-10-22 | ||||
| 2019-03-31 | $21.00M 10-Q · filed 2020-10-22 | |||||
| 2018-12-31 | $108.00M 10-K · filed 2021-02-12 | |||||
| 2018-09-30 | $25.00M 10-Q · filed 2019-11-01 | $50.00M derived: sum of 2 quarters · filed 2019-11-01 | $70.00M derived: sum of 3 quarters · filed 2019-11-01 | |||
| 2018-06-30 | $25.00M 10-Q · filed 2019-11-01 | $45.00M derived: sum of 2 quarters · filed 2019-11-01 | ||||
| 2018-03-31 | $20.00M 10-Q · filed 2019-11-01 | |||||
| 2017-12-31 | $180.00M 10-K · filed 2020-02-18 | |||||
| 2016-12-31 | $76.00M 10-K · filed 2019-02-19 | |||||
| 2015-12-31 | $7.71M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $31.00M 10-K · filed 2018-02-16 | $31.58M 10-K · filed 2016-02-11 | |||
| 2015-09-30 | $23.29M 10-Q · filed 2015-10-28 | |||||
| 2014-12-31 | $26.00M 10-K · filed 2017-02-16 | $25.32M 10-K · filed 2015-02-12 | ||||
| 2013-12-31 | $20.78M 10-K · filed 2016-02-11 | |||||
| 2012-12-31 | $25.77M 10-K · filed 2015-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |